MPM BioImpact’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-896,915
| Closed | -$10.4M | – | 49 |
|
|
2024
Q3 | $10.4M | Buy |
896,915
+14,978
| +2% | +$173K | 1.56% | 22 |
|
|
2024
Q2 | $10.4M | Buy |
881,937
+121,215
| +16% | +$1.43M | 1.61% | 23 |
|
|
2024
Q1 | $9.02M | Buy |
+760,722
| New | +$9.02M | 1.45% | 26 |
|
|
2023
Q4 | – | Sell |
-577,958
| Closed | -$5.57M | – | 33 |
|
|
2023
Q3 | $5.57M | Sell |
577,958
-183,580
| -24% | -$1.77M | 1.49% | 23 |
|
|
2023
Q2 | $6.85M | Buy |
+761,538
| New | +$6.85M | 1.38% | 22 |
|